Table 2 (abstract A31). See text for description
From: Abstracts of the ICARE 2023 77th SIAARTI National Congress
|  | THRIVE group (n=5) | Control group (n=5) | P value§ |
|---|---|---|---|
SctO2 | |||
 Baseline | 72 (70, 77) | 71 (68, 72) | 0.460 |
 At the end of surgery | 93 (92, 94) | 71 (68, 73) | 0.015 |
SpO2 | |||
 At induction of anesthesia | 100 (99, 100) | 99 (98, 100) | 0.100 |
 At the end of anesthesia | 100 (99, 100) | 98 (98, 99) | > 0.999 |
Incidence of SpO2 ≤ 94% | 0 (0) | 0 (0) | > 0.999 |
Lowest pH | 7.31 (7.27, 7.36) | 7.40 (7.38, 7.43) | < 0.001 |
Incidence of pH < 7.30 | 5 (100) | 0 (0) | 0.008 |
pH at discharge from PACU | 7.42 (7.41, 7.44) | 7.40 (7.39, 7.42) | 0.387 |
PaCO2, mmHg | |||
 Baseline | 35 (34, 36) | 34 (33, 37) | > 0.999 |
 At the end of anesthesia | 49 (46, 50) | 43 (42, 44) | < 0.048 |
 Total monitoring time | 48 (46, 48) | 39 (36, 42) | 0.018 |
Incidence of PaCO2 > 65 mmHg | 2 (40) | 0 (0) | 0.444 |
Peak PaCO2, mmHg | 61 (60, 61) | 43 (41, 45) | 0.019 |
PaCO2 at discharge from PACU, mmHg | 36 (36, 41) | 40 (37, 42) | 0.533 |
Mean blood pressure, mmHg | |||
 At induction of anesthesia | 100 (98, 106) | 95 (90, 97) | 0.190 |
 At the end of anesthesia | 94 (83, 97) | 96 (95, 97) | 0.533 |
 At discharge from PACU | 93 (87, 103) | 94 (90, 100) | 0.904 |
Heart rate, bpm | |||
 At induction of anesthesia | 96 (80, 100) | 72 (65, 77) | 0.109 |
 At the end of anesthesia | 82 (70, 83) | 65 (61. 70) | 0.381 |
 At discharge from PACU | 75 (71, 82) | 74 (66, 79) | 0.458 |
Duration of surgery, min | 12 (10, 12) | 14 (12, 15) | 0.262 |
Duration of anesthesia, min | 21 (20, 24) | 26 (24, 28) | 0.190 |
Borg dyspnea score at the end of surgery | 0 (0, 0) | 0 (0, 0) | > 0.999 |